Coated Tissue Engineering Scaffold

• US 20090163936A1
• Filed: 12/21/2007
• Published: 06/25/2009
• Est. Priority Date: 12/21/2007
• Status: Abandoned Application

• Current Assignee: Ethicon Incorporated (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Yang, Chunlin, Kong, Wei
• Application Number:
  US11/962,241
• Publication Number:
  US 20090163936A1
• Time in Patent Office: Days
• US Class Current: 606/151
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/41 Anti-inflammatory agents, e.g. NSAIDs
• CPC Class Codes: A61L 2300/414 Growth factors
• CPC Class Codes: A61L 2300/606 Coatings
• CPC Class Codes: A61L 27/20 Polysaccharides
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence

Abstract

The invention concerns scaffolds comprising a coating on at least one surface that partially penetrates into the void spaces of the scaffold. The invention further concerns scaffolds comprising a partially penetrated anti-adhesion absorbable membrane layer.

Claims

1. A device comprising

a) a scaffold having one or more surfaces the scaffold comprising a plurality of fibers with outer surfaces and one or more void spaces defined by the outer surfaces of the fibers;

and

b) a coating on at least one surface of the scaffold

wherein the coating fills at least one void space.

2. The device of claim 1 wherein the fibers are hydrophobic and the coating is hydrophilic.

3. The device of claim 1 wherein the coating comprises a material selected from the group consisting of hyaluronic acid, carboxymethylcellulose and combinations thereof.

4. The device of claim 3 wherein the coating further comprises oxidized regenerated celluloses.

5. The device of claim 3 wherein the material is stabilized by cross linking.

6. The device of claim 5 wherein the material is cross-linked by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride.

7. The device of claim 1 wherein the scaffold further comprises reinforcing material.

8. The device of claim 7 wherein the reinforcing material is an absorbable or nonabsorbable textile.

9. The device of claim 8 wherein the reinforcing material comprises a bioabsorbable material selected from the group consisting of polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), copolymers and combinations thereof.

10. The device of claim 9 wherein the bioabsorbable material is a copolymer of lactide and glycolide.

11. The device of claim 7 wherein the reinforcing material comprises biocompatible materials based on natural polymers.

12. The device of claim 7 wherein the reinforcing material comprises a nonresorbable biocompatible fiber selected from the group consisting of polyethylene, polyethylene terephthalate, poly(tetrafluoroethylene), polycarbonate, polypropylene, poly(vinyl alcohol) and combinations thereof.

13. The device of claim 7 wherein the reinforcing material comprises bioabsorbable glass.

14. The device of claim 1 wherein the coating provides an anti-adhesion barrier.

15. The device of claim 1 wherein the coating has a thickness of about 5 um to about 250 um.

16. The device of claim 1 wherein the coating penetrates into the void spaces of the scaffold about 1 um to about 100 um from the surface of the scaffold to which the coating is applied.

17. The device of claim 1 wherein the scaffold comprises a biocompatible polymer.

18. The device of claim 17 wherein the biocompatible polymer is selected from the group consisting of aliphatic polyesters, poly(amino acids), poly(propylene fumarate), copoly(ether-esters), polyalkylenes oxalates, polyamides, tyrosine derived polycarbonates, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, biosynthetic polymers based on sequences found in collagen, elastin, thrombin, fibronectin, starches, poly(amino acid), gelatin, alginate, pectin, fibrin, oxidized cellulose, chitin, chitosan, tropoelastin, hyaluronic acid, ribonucleic acids, deoxyribonucleic acids, polypeptides, proteins, polysaccharides, polynucleotides polyolefins, polyurethanes, polyesters, polyamides and combinations thereof.

19. The device of claim 1 wherein the scaffold is formed using tissue grafts.

20. The device of claim 1 further comprising one or more bioactive agents.

21. The device of claim 1 further comprising viable tissue.

22. The device of claim 1 comprising cells incorporated into the scaffold structure.

24. The device of claim 1 further comprising a biological effector for use in gene therapy techniques.

25. The device of claim 24 wherein the biological effector is selected from the group consisting of nucleic acid, virus, virus particle and non-viral vector.

23. The device of claim 23 wherein the cells are selected from the group consisting of osteocytes, osteoblasts, osteoclasts, fibroblasts, stem cells, pluripotent cells, chondrocyte progenitors, chondrocytes, endothelial cells, macrophages, leukocytes, adipocytes, monocytes, plasma cells, mast cells, umbilical cord cells, placental cells, stromal cells, epithelial cells, myoblasts, tenocytes, ligament fibroblasts, neurons, bone marrow cells, synoviocytes, precursor cells derived from adipose tissue, peripheral blood progenitor cells, genetically transformed cells, precursor cells isolated from adult tissue and combinations thereof.